Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Huntington Disease | 13 | 2022 | 142 | 2.100 |
Why?
|
| Nerve Tissue Proteins | 13 | 2024 | 1130 | 1.070 |
Why?
|
| Drosophila melanogaster | 16 | 2026 | 856 | 1.040 |
Why?
|
| Huntingtin Protein | 13 | 2022 | 64 | 1.010 |
Why?
|
| Alzheimer Disease | 10 | 2026 | 878 | 0.870 |
Why?
|
| tau Proteins | 7 | 2026 | 252 | 0.800 |
Why?
|
| Drosophila | 20 | 2025 | 794 | 0.760 |
Why?
|
| Drosophila Proteins | 8 | 2025 | 791 | 0.700 |
Why?
|
| Nuclear Proteins | 7 | 2016 | 1226 | 0.590 |
Why?
|
| Spinocerebellar Ataxias | 6 | 2022 | 260 | 0.580 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 81 | 0.530 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 117 | 0.520 |
Why?
|
| Disease Models, Animal | 23 | 2026 | 4692 | 0.520 |
Why?
|
| Tauopathies | 3 | 2024 | 71 | 0.500 |
Why?
|
| Neurons | 11 | 2026 | 2009 | 0.490 |
Why?
|
| alpha-Synuclein | 4 | 2025 | 139 | 0.470 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 567 | 0.440 |
Why?
|
| Ataxin-1 | 7 | 2022 | 162 | 0.410 |
Why?
|
| Animals | 39 | 2026 | 34288 | 0.410 |
Why?
|
| Brain | 12 | 2026 | 3253 | 0.410 |
Why?
|
| Parkinson Disease | 4 | 2025 | 737 | 0.390 |
Why?
|
| Neurodegenerative Diseases | 2 | 2022 | 290 | 0.350 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2015 | 49 | 0.330 |
Why?
|
| Myotonic Dystrophy | 2 | 2013 | 120 | 0.320 |
Why?
|
| Neuropeptides | 1 | 2009 | 111 | 0.300 |
Why?
|
| RNA Interference | 5 | 2019 | 495 | 0.290 |
Why?
|
| Peptides | 6 | 2022 | 725 | 0.280 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2021 | 100 | 0.270 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2021 | 37 | 0.270 |
Why?
|
| Cerebellum | 2 | 2022 | 460 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2025 | 3439 | 0.260 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 553 | 0.260 |
Why?
|
| Transcription Factors | 4 | 2021 | 2462 | 0.250 |
Why?
|
| Corpus Striatum | 6 | 2022 | 97 | 0.250 |
Why?
|
| Autophagy | 2 | 2021 | 424 | 0.250 |
Why?
|
| Friedreich Ataxia | 2 | 2016 | 48 | 0.240 |
Why?
|
| Amyloid beta-Peptides | 3 | 2026 | 238 | 0.240 |
Why?
|
| Ubiquitin | 1 | 2006 | 133 | 0.230 |
Why?
|
| Animals, Genetically Modified | 7 | 2023 | 332 | 0.230 |
Why?
|
| Proteolysis | 2 | 2017 | 195 | 0.230 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2006 | 121 | 0.230 |
Why?
|
| Mice | 19 | 2025 | 18397 | 0.230 |
Why?
|
| Cells, Cultured | 6 | 2021 | 2947 | 0.220 |
Why?
|
| Cell Line | 6 | 2021 | 2591 | 0.210 |
Why?
|
| Gene Regulatory Networks | 3 | 2021 | 379 | 0.210 |
Why?
|
| Transcriptome | 5 | 2026 | 1141 | 0.210 |
Why?
|
| Fibroblasts | 2 | 2018 | 869 | 0.200 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 364 | 0.200 |
Why?
|
| Haploinsufficiency | 1 | 2025 | 265 | 0.200 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2025 | 284 | 0.190 |
Why?
|
| Neuroglia | 2 | 2023 | 223 | 0.190 |
Why?
|
| ras Proteins | 2 | 2013 | 147 | 0.180 |
Why?
|
| Humans | 37 | 2026 | 132158 | 0.180 |
Why?
|
| Electrical Synapses | 1 | 2021 | 14 | 0.170 |
Why?
|
| Ataxins | 4 | 2013 | 112 | 0.170 |
Why?
|
| Apolipoprotein E2 | 1 | 2020 | 16 | 0.170 |
Why?
|
| Mutation | 9 | 2024 | 6206 | 0.170 |
Why?
|
| Transcription, Genetic | 1 | 2025 | 1399 | 0.170 |
Why?
|
| DNA-Binding Proteins | 2 | 2021 | 1965 | 0.160 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 52 | 0.160 |
Why?
|
| Brain Stem | 1 | 2021 | 112 | 0.160 |
Why?
|
| Behavior, Animal | 3 | 2021 | 502 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2024 | 2367 | 0.160 |
Why?
|
| Proteomics | 2 | 2016 | 612 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2016 | 573 | 0.150 |
Why?
|
| Protein Kinase C beta | 1 | 2019 | 17 | 0.150 |
Why?
|
| Sex Factors | 1 | 2023 | 1352 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 381 | 0.150 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 329 | 0.150 |
Why?
|
| Protein Kinases | 2 | 2019 | 322 | 0.140 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 116 | 0.140 |
Why?
|
| Models, Biological | 2 | 2017 | 1396 | 0.140 |
Why?
|
| Amyloidosis | 1 | 2019 | 70 | 0.140 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2018 | 249 | 0.140 |
Why?
|
| DNA Damage | 1 | 2021 | 527 | 0.130 |
Why?
|
| Muscles | 2 | 2009 | 220 | 0.130 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2017 | 38 | 0.130 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2016 | 812 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1617 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2026 | 1851 | 0.120 |
Why?
|
| Antioxidants | 2 | 2016 | 336 | 0.120 |
Why?
|
| Genome | 1 | 2018 | 474 | 0.120 |
Why?
|
| Dynamin I | 1 | 2015 | 2 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 421 | 0.120 |
Why?
|
| Repressor Proteins | 2 | 2016 | 782 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 113 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2021 | 1571 | 0.100 |
Why?
|
| Introns | 1 | 2015 | 288 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 252 | 0.100 |
Why?
|
| Sirolimus | 1 | 2015 | 230 | 0.100 |
Why?
|
| Iron | 1 | 2016 | 308 | 0.100 |
Why?
|
| Plaque, Amyloid | 2 | 2026 | 70 | 0.090 |
Why?
|
| Genomics | 2 | 2023 | 1633 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 299 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2013 | 189 | 0.090 |
Why?
|
| Diacylglycerol Kinase | 1 | 2012 | 17 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 4550 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1024 | 0.080 |
Why?
|
| HEK293 Cells | 3 | 2021 | 810 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2025 | 2873 | 0.080 |
Why?
|
| Gene Expression | 3 | 2026 | 1508 | 0.080 |
Why?
|
| Matrix Metalloproteinases | 1 | 2010 | 62 | 0.080 |
Why?
|
| Transgenes | 2 | 2013 | 324 | 0.080 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 3714 | 0.080 |
Why?
|
| Ganglia | 1 | 2009 | 15 | 0.080 |
Why?
|
| Neurosecretory Systems | 1 | 2009 | 22 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2021 | 4699 | 0.080 |
Why?
|
| Neurites | 1 | 2009 | 45 | 0.080 |
Why?
|
| Genome-Wide Association Study | 3 | 2025 | 1847 | 0.080 |
Why?
|
| Mushroom Bodies | 1 | 2009 | 50 | 0.080 |
Why?
|
| Larva | 1 | 2009 | 251 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2009 | 142 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 372 | 0.070 |
Why?
|
| Male | 9 | 2025 | 65464 | 0.070 |
Why?
|
| Female | 10 | 2025 | 71430 | 0.070 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2007 | 11 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2009 | 289 | 0.070 |
Why?
|
| Protein Stability | 2 | 2021 | 166 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2021 | 363 | 0.060 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2006 | 11 | 0.060 |
Why?
|
| CELF1 Protein | 1 | 2006 | 36 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2006 | 236 | 0.060 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2006 | 58 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2006 | 124 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2026 | 29 | 0.060 |
Why?
|
| Iron-Binding Proteins | 2 | 2016 | 33 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2025 | 3458 | 0.060 |
Why?
|
| Protein Folding | 1 | 2006 | 216 | 0.060 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 173 | 0.060 |
Why?
|
| RNA Polymerase II | 1 | 2025 | 90 | 0.060 |
Why?
|
| Aging | 2 | 2023 | 1274 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 452 | 0.060 |
Why?
|
| Eye | 1 | 2006 | 227 | 0.050 |
Why?
|
| Protein Conformation | 1 | 2006 | 734 | 0.050 |
Why?
|
| Paralysis | 1 | 2024 | 29 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2021 | 2421 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2025 | 285 | 0.050 |
Why?
|
| Transferases (Other Substituted Phosphate Groups) | 1 | 2023 | 6 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 665 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2015 | 266 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 18 | 0.050 |
Why?
|
| Glucosylceramidase | 1 | 2023 | 35 | 0.050 |
Why?
|
| Rett Syndrome | 1 | 2025 | 229 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2025 | 298 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 2 | 2014 | 75 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1235 | 0.050 |
Why?
|
| Transglutaminases | 1 | 2022 | 27 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2025 | 2358 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2024 | 3864 | 0.050 |
Why?
|
| Motor Activity | 2 | 2015 | 506 | 0.050 |
Why?
|
| Protein Binding | 1 | 2025 | 1674 | 0.040 |
Why?
|
| Lysosomes | 1 | 2023 | 270 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4734 | 0.040 |
Why?
|
| Locomotion | 1 | 2021 | 59 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 2021 | 106 | 0.040 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 81 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 82 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 622 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2585 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 95 | 0.040 |
Why?
|
| Mitochondria | 2 | 2016 | 774 | 0.040 |
Why?
|
| Homozygote | 1 | 2020 | 550 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 590 | 0.040 |
Why?
|
| Heterozygote | 1 | 2020 | 728 | 0.030 |
Why?
|
| Species Specificity | 1 | 2018 | 496 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 902 | 0.030 |
Why?
|
| Aluminum | 1 | 2016 | 15 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2016 | 38 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 291 | 0.030 |
Why?
|
| Manganese | 1 | 2016 | 59 | 0.030 |
Why?
|
| Copper | 1 | 2016 | 72 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 418 | 0.030 |
Why?
|
| Zinc | 1 | 2016 | 128 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 122 | 0.030 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 27 | 0.030 |
Why?
|
| Malondialdehyde | 1 | 2015 | 49 | 0.030 |
Why?
|
| Fear | 1 | 2016 | 195 | 0.030 |
Why?
|
| Thioxanthenes | 1 | 2014 | 2 | 0.030 |
Why?
|
| Postmortem Changes | 1 | 2014 | 12 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 37 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1020 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1863 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2015 | 125 | 0.030 |
Why?
|
| Morpholines | 1 | 2014 | 68 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 179 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 1 | 2015 | 210 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2019 | 725 | 0.030 |
Why?
|
| Glutathione | 1 | 2015 | 198 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 178 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 176 | 0.030 |
Why?
|
| NEDD8 Protein | 1 | 2013 | 12 | 0.020 |
Why?
|
| Cullin Proteins | 1 | 2013 | 13 | 0.020 |
Why?
|
| Ubiquitins | 1 | 2013 | 39 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2014 | 439 | 0.020 |
Why?
|
| Myoblasts | 1 | 2013 | 34 | 0.020 |
Why?
|
| Farnesyltranstransferase | 1 | 2012 | 8 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 1019 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 467 | 0.020 |
Why?
|
| Caspase 7 | 1 | 2012 | 7 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 1107 | 0.020 |
Why?
|
| Aged | 2 | 2025 | 21279 | 0.020 |
Why?
|
| Homeostasis | 1 | 2016 | 715 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 127 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 144 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 193 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 305 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 2994 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 659 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 664 | 0.020 |
Why?
|
| Histones | 1 | 2014 | 545 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 450 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 387 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 160 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11034 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 237 | 0.020 |
Why?
|
| Caspases | 1 | 2010 | 157 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 240 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2012 | 452 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 636 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3532 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 960 | 0.020 |
Why?
|
| Adult | 2 | 2023 | 31755 | 0.020 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2007 | 16 | 0.020 |
Why?
|
| Genes, Insect | 1 | 2007 | 113 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2007 | 253 | 0.020 |
Why?
|
| Genome, Human | 1 | 2012 | 1340 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 482 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1320 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7603 | 0.010 |
Why?
|
| Middle Aged | 1 | 2014 | 28939 | 0.010 |
Why?
|